Skip to search formSkip to main contentSkip to account menu

Ablavar

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Methods Simulation study: In vitro studies have shown Ablavar to be 80-90% bound to albumin, with up to 10 fold relaxivity… 
Review
2013
Review
2013
While research exploring the utility of intravascular gadolinium based contrast agents (GBCA), such as gadofosveset (Vasovist… 
Review
2012
Review
2012
Gadofosveset trisodium (Ablavar®, formerly Vasovist®) is the first intravascular contrast agent approved for clinical use in… 
2012
2012
To investigate enhancement of hepatic lesions with gadofosveset trisodium (Gdfos) (Ablavar) (blood pool agent) compared with the… 
2012
2012
Purpose / Introduction: Clinical 7T MR imaging is a rapidly emergent modality, yet the behavior of common lanthanide chelates at… 
Review
2012
Review
2012
Background Although contrast-enhanced first-pass MRA (FP-MRA) is frequently used to visualize the thoracic vasculature, it may… 
2010
2010
INTRODUCTION. Pulse wave velocity (PWV) is an indirect measure of vascular stiffness that is used as a biomarker of…